Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The latest price target for Replimune Group (NASDAQ:REPL) was reported by Cantor Fitzgerald on April 13, 2026. The analyst firm set a price target for $0.00 expecting REPL to fall to within 12 months ...

Git isn't hard to learn, and when you combine Git with GitLab, you've made it a whole lot easier to share code and manage a common Git commit history with the rest of your team. This tutorial shows ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

At a Senate hearing, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Wednesday that he "had nothing to do” with the FDA’s decision to reject Replimune’s (REPL) lead candidate ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

With a two-year target to move 50% of government sectors, services and operations to agentic artificial intelligence, the UAE is positioning autonomous systems as the next phase of digital government ...

Working It is the FT's workplace, future of work and leadership brand, led by Isabel Berwick. Sign up for Isabel's weekly Working It newsletter (here) which offers a sideways glance at the week's big ...

A leading global aerospace company and top U.S. exporter, Boeing develops, manufactures and services commercial airplanes, defense products and space systems for customers in more than 150 countries.

Kiara Taylor has worked as a financial analyst for more than a decade. Her career has involved a number of financial firms, including Fifth Third Bank, JPMorgan, and Citibank. She has filled a number ...